Octant Bio

Octant (Octant Bio) is a precision-medicine and therapeutics company based in Emeryville, California, founded by Sri Kosuri and Ramsey Homsany. Octant engineers small-molecule drugs that modulate cellular mechanisms behind serious disease, with a focus on protein misfolding and mistrafficking disorders. Its Navigator platform merges synthetic biology, massively parallel experimentation in human cells, high-throughput chemistry, and AI/ML to understand and modulate how target proteins actually behave inside cells. Programs span rare genetic diseases (including autosomal dominant retinitis pigmentosa and Fabry disease), oncology, metabolism, and immunology. Octant is backed by Andreessen Horowitz (a16z) and Catalio Capital Management. As of this profile Octant publishes no public developer API, SDK, or developer portal; this record captures the company's public web identity in the API Evangelist network.

Octant Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Precision Medicine, Drug Discovery, and Therapeutics.

Octant Bio’s developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPrecision MedicineDrug DiscoveryTherapeuticsSynthetic BiologyPharmaceuticalsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/octant-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

About

About

Blog

Blog

Source (apis.yml)

aid: octant-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/octant-bio.png
name: Octant Bio
description: Octant (Octant Bio) is a precision-medicine and therapeutics company based in Emeryville, California, founded
  by Sri Kosuri and Ramsey Homsany. Octant engineers small-molecule drugs that modulate cellular mechanisms behind serious
  disease, with a focus on protein misfolding and mistrafficking disorders. Its Navigator platform merges synthetic biology,
  massively parallel experimentation in human cells, high-throughput chemistry, and AI/ML to understand and modulate how target
  proteins actually behave inside cells. Programs span rare genetic diseases (including autosomal dominant retinitis pigmentosa
  and Fabry disease), oncology, metabolism, and immunology. Octant is backed by Andreessen Horowitz (a16z) and Catalio Capital
  Management. As of this profile Octant publishes no public developer API, SDK, or developer portal; this record captures
  the company's public web identity in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/octant-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- Catalio Capital Management
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Precision Medicine
- Drug Discovery
- Therapeutics
- Synthetic Biology
- Pharmaceuticals
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.octant.bio/
- type: About
  url: https://www.octant.bio/about
- type: Blog
  url: https://www.octant.bio/blog
- type: Support
  url: https://www.octant.bio/contact
- type: PrivacyPolicy
  url: https://www.octant.bio/privacy-policy
- type: DomainSecurity
  url: security/octant-bio-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1